Catalent, Inc. is a leading contract development and manufacturing organization (CDMO) that partners with pharmaceutical, biotech, and consumer health companies to develop and deliver high-quality products that enhance people's lives. With a focus on oral dose development, bioavailability enhancement, and integrated development solutions, Catalent offers a wide range of services and technologies to support the development and manufacturing of pharmaceutical products.
With a strong presence in North America, Europe, Asia Pacific, and Latin America, Catalent is known for its expertise in drug delivery technologies, including oral technologies, softgel technologies, and inhalation technologies. The company also offers specialized services for biologics, gene therapy, and clinical supply, making it a trusted partner for companies in the pharmaceutical and healthcare industries.
Generated from the website